Comerica Bank
IBB icon

Comerica Bank’s iShares Biotechnology ETF IBB Stock Holding History

Comerica Bank’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.49M Buy
14,730
+1,789
+14% +$291K 0.01% 1006
2025
Q3 		$1.87M Sell
12,941
-2,928
-18% -$400K 0.01% 1196
2025
Q2 		$2.01M Sell
15,869
-557
-3% -$68.4K 0.01% 1128
2025
Q1 		$2.1M Sell
16,426
-1,303
-7% -$177K 0.01% 1078
2024
Q4 		$2.34M Buy
17,729
+226
+1% +$31.8K 0.01% 1058
2024
Q3 		$2.55M Sell
17,503
-651
-4% -$94.2K 0.01% 1031
2024
Q2 		$2.49M Sell
18,154
-475
-3% -$63.4K 0.01% 1022
2024
Q1 		$2.56M Buy
18,629
+1,169
+7% +$160K 0.01% 1060
2023
Q4 		$2.37M Sell
17,460
-1,606
-8% -$196K 0.01% 1076
2023
Q3 		$2.33M Buy
+19,066
New +$2.42M 0.01% 1001
2022
Q2 		– Sell
-1,646
Closed -$212K – 2166
2022
Q1 		$212K Hold
1,646
– – ﹤0.01% 2085
2021
Q4 		$210K Buy
1,646
+333
+25% +$51.6K ﹤0.01% 2079
2021
Q3 		$208K Sell
1,313
-29
-2% -$4.88K ﹤0.01% 2137
2021
Q2 		$221K Sell
1,342
-71
-5% -$10.9K ﹤0.01% 2230
2021
Q1 		$219K Buy
1,413
+19
+1% +$3.02K ﹤0.01% 2231
2020
Q4 		$230K Buy
+1,394
New +$199K ﹤0.01% 2210
2020
Q2 		– Sell
-2,459
Closed -$310K – 2282
2020
Q1 		$310K Buy
+2,459
New +$283K ﹤0.01% 1940
2019
Q2 		– Sell
-8,047
Closed -$916K – 2301
2019
Q1 		$916K Buy
+8,047
New +$883K 0.01% 1624
2018
Q3 		– Sell
-1,833
Closed -$217K – 2286
2018
Q2 		$217K Sell
1,833
-268
-13% -$28.7K ﹤0.01% 2176
2018
Q1 		$222K Sell
2,101
-1
-0% -$111 ﹤0.01% 2154
2017
Q4 		$244K Buy
+2,102
New +$225K ﹤0.01% 2141
2016
Q1 		– Sell
-2,802
Closed -$282K – 2095
2015
Q4 		$282K Buy
+2,802
New +$304K ﹤0.01% 1886
2013
Q4 		– Sell
-17,877
Closed -$1.25M – 2375
2013
Q3 		$1.25M Sell
17,877
-546
-3% -$35.8K 0.01% 1487
2013
Q2 		$1.07M Buy
+18,423
New +$1.06M 0.01% 1358

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Comerica Bank's IBB Position: Q4 2025 in Review

Comerica Bank increased its iShares Biotechnology ETF (IBB) stake by 14% in Q4 2025, buying an estimated $291K and bringing the position to 14,730 shares worth $2.49M. The position accounts for 0.01% of the portfolio, ranked #1006.

Comerica Bank first reported a position in IBB in Q2 2013 and has held it in 24 quarters since. The position peaked at $2.56M in Q1 2024. 956 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Comerica Bank held 14,730 shares of iShares Biotechnology ETF worth $2.49M as of Q4 2025.
  • Comerica Bank bought 1,789 iShares Biotechnology ETF shares in Q4 2025, an estimated $291K.
  • iShares Biotechnology ETF made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1006 holding.
  • Comerica Bank first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 24 quarters since.
  • Comerica Bank's iShares Biotechnology ETF position peaked at $2.56M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.